EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of NMDA Receptor and TRPM4 Activity in Hippocampal Neurons with the NMDA Receptor/TRPM4 Interface Inhibitor Brophenexin

Jordan Casby, Rachel K Allen, Ezequiel Marron Fernandez de Velasco, Stanley A Thayer

Neurotoxicity Research · 2026

DOI: 10.1007/s12640-026-00788-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurotoxicity Research, 2026. Verfasst von Jordan Casby und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, USA. casby002@umn.edu. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, TRPM Cation Channels, Hippocampus, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excitotoxic signaling mediated by N-methyl-D-aspartate receptors (NMDARs) is inhibited by NMDAR/TRPM4 complex inhibitors such as brophenexin (BPN). We used rat hippocampal neurons grown in culture to determine the effects of BPN on NMDAR and TRPM4 function. NMDA evoked concentration-dependent increases in intracellular Ca2+ that were inhibited by 10 µM BPN in a non-competitive manner. In contrast, the TRPM4 inhibitor 4-chloro-2-(2-(naphthalene-1-yloxy) acetamido) benzoic acid (NBA) increased the potency of NMDA at 22 °C. BPN inhibition of NMDAR-mediated increases in Ca2+ was fully reversible and recovered by rapid (30 s) and slow (90 min) processes. The rapid phase of recovery from BPN inhibition was mediated by trafficking through recycling endosomes as indicated by blockade of this phase with bafilomycin A1 an agent that prevents endosomal acidification. The full recovery of NMDAR function observed 90 min after washout of BPN was not affected by this treatment. Immunocytochemistry experiments suggested that BPN did not directly alter NMDAR trafficking but instead changes in surface and internal GluN2B immunoreactivity were likely homeostatic responses to inhibition of NMDAR function by BPN. In the presence of MK-801 to block NMDARs, 10 µM NBA inhibited spontaneous network-driven Ca2+ spiking by 74 ± 11% whereas 10 µM BPN reduced activity by 49 ± 6%. Thus, BPN inhibits TRPM4-dependent activity. In summary, BPN is a non-competitive, fully reversible inhibitor of NMDAR-mediated Ca2+ influx and produces a modest inhibition of TRPM4 function. Functional inhibition of these ion channels likely contributes to the neuroprotective properties of NMDAR/TRPM4 interface inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, N-Methyl-D-AspartateTRPM Cation ChannelsHippocampusNeuronsAnimalsCells, CulturedRatsCalciumRats, Sprague-DawleyDose-Response Relationship, Drug

Stichwörter der Autor:innen

Ca2+ signalingExcitotoxicityNMDA receptorNeuroprotectionTRPM4

Substanzen

Receptors, N-Methyl-D-AspartateTRPM Cation ChannelsTRPM4 protein, ratCalcium

Autor:innen und Institutionen

  • Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, USA. casby002@umn.edu.
  • Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, USA.

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Casby, J., Allen, R. K., Marron Fernandez de Velasco, E., & Thayer, S. A. (2026). Modulation of NMDA Receptor and TRPM4 Activity in Hippocampal Neurons with the NMDA Receptor/TRPM4 Interface Inhibitor Brophenexin. Neurotoxicity Research. https://doi.org/10.1007/s12640-026-00788-0

Vancouver

Casby J, Allen RK, Marron Fernandez de Velasco E, Thayer SA. Modulation of NMDA Receptor and TRPM4 Activity in Hippocampal Neurons with the NMDA Receptor/TRPM4 Interface Inhibitor Brophenexin. Neurotoxicity Research. 2026. doi:10.1007/s12640-026-00788-0

BibTeX
@article{Casby2026,
  author = {Casby, Jordan and Allen, Rachel K and Marron Fernandez de Velasco, Ezequiel and Thayer, Stanley A},
  title = {Modulation of NMDA Receptor and TRPM4 Activity in Hippocampal Neurons with the NMDA Receptor/TRPM4 Interface Inhibitor Brophenexin},
  journal = {Neurotoxicity Research},
  year = {2026},
  doi = {10.1007/s12640-026-00788-0}
}
Kostenlos starten →